Pharmascience PMS-Losartan product recall (2021-10-13)
- Starting date:
- October 13, 2021
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-76645
Last updated:
2021-10-15
Summary
-
Product:
A. PMS-Losartan 25mgB. PMS-Losartan 50mg
C. PMS-Losartan 100mg
A. PMS-Losartan 25mg
B. PMS-Losartan 50mg
C. PMS-Losartan 100mg
Reason
Presence of impurity (5-[4'-[(5-(Azidomethyl)-2-butyl-4-chloro-1H-imidazol-1-yl)methyl]-[1,1'-biphenyl]-2-yl]-1H-tetrazole) above the acceptable concentration limit in affected lots
Depth of distribution
Retailers
Affected products
A. PMS-Losartan 25mg
DIN, NPN, DIN-HIM
DIN 02309750
Dosage form
Tablet
Strength
Losartan Potassium 25mg
Lot or serial number
629303, 636356
Companies
- Recalling Firm
-
Pharmascience Inc.
6111 Royalmount Avenue
Montreal
H4P 2T4
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
6111 Royalmount Avenue
Montreal
H4P 2T4
CANADA
B. PMS-Losartan 50mg
DIN, NPN, DIN-HIM
DIN 02309769
Dosage form
Tablet
Strength
Losartan Potassium 50mg
Lot or serial number
629302, 636348, 636357
Companies
- Recalling Firm
-
Pharmascience Inc.
6111 Royalmount Avenue
Montreal
H4P 2T4
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
6111 Royalmount Avenue
Montreal
H4P 2T4
CANADA
C. PMS-Losartan 100mg
DIN, NPN, DIN-HIM
DIN 02309777
Dosage form
Tablet
Strength
Losartan Potassium 100mg
Lot or serial number
629306, 629307,636346,636358
Companies
- Recalling Firm
-
Pharmascience Inc.
6111 Royalmount Avenue
Montreal
H4P 2T4
CANADA
- Marketing Authorization Holder
-
Pharmascience Inc.
6111 Royalmount Avenue
Montreal
H4P 2T4
CANADA